The blood-testis barrier as a target of some chemotherapeutic agents

Area of Science:

• Toxicology
• Reproductive Biology
• Oncology

Background:

• Chemotherapeutic agents can cause testicular damage, potentially impairing male fertility.
• Metal-based antineoplastic complexes, specifically titanocene dichloride and budotitane, were investigated for their impact on the blood-testis barrier (BTB).

Purpose of the Study:

• To evaluate the effects of titanocene dichloride and budotitane on the integrity of the blood-testis barrier (BTB).
• To understand the potential mechanisms of testicular toxicity induced by metal-based anticancer drugs.

Main Methods:

• Male mice were administered titanocene dichloride or budotitane in vivo.
• Seminiferous tubule fragments were isolated and incubated with horseradish peroxidase to assess BTB permeability.
• Ultrastructural analysis was performed to detect tracer leakage across the BTB.

Main Results:

• Titanocene dichloride treatment resulted in the disruption of the BTB, evidenced by horseradish peroxidase presence within the tubules.
• Animals treated with budotitane did not exhibit BTB disruption, indicating a lack of permeability changes.

Conclusions:

• Titanocene dichloride demonstrates toxicity towards the blood-testis barrier, posing a risk to male reproductive health.
• The findings suggest that the toxicity of metal-based antineoplastic drugs on the BTB may have broader implications for other biological barriers.